After being fired, I became the light of medicine

Chapter 146 Winter is coming, what should we do with BI's catalyst? (Subscribe)

Area A of the Dialysis Center of West China Hospital.

"Xiaoqin, how come it's so fast today? Everyone's on the plane in 25 minutes?"

1:25 p.m., nurse preparation room at the dialysis center.

Nurse Sister Wang looked at Fang Xiaoqin from the same group who walked in with a "treatment tray" and asked.

Fang Xiaoqin, who was also one of the nurses at the dialysis center, nodded and placed the treatment tray on the operating table.

"Sister Wang, it's not that I'm fast, didn't you see how many people got on the plane at noon today?"

"In the past, the number of patients who boarded the machine at noon was usually full every day with 30 patients. But today, it was not full at all, with only 24."

"So, Xiao Liu and I were all on the plane in less than half an hour."

Nurse Wang was a little surprised. She prepared various medical supplies and said:
"I originally thought that only the 7pm dialysis batch had fewer people, but I didn't expect that the noon batch also had fewer people!"

"Noontime is the most popular and busiest time. After the show, people go home for dinner. It used to be packed every day!"

Fang Xiaoqin nodded:

"This is all because of that 'Kidney Toxin Clearing Dialysis Needle'."

As she spoke, she suddenly lowered her voice:
"And when I was helping patients get on the machine just now, I heard many patients discussing the 'Kidney Du Qing dialysis needle'. Many people were planning to switch to hemodialysis once a week after this week's dialysis, and use 'Kidney Du Qing' for the remaining two times."

"Sister Wang, do you think that Qingshan Pharmaceutical's 'Kidney Toxin Clearing Dialysis Needle' is really that good?"

Nurse Sister Wang is a senior nurse in the dialysis center and is well-informed. She said:

"How could it be false? I asked several doctors and they all praised it highly!"

"And I heard that this drug has been sold to the United States and Europe. Many top foreign hospitals have introduced it. It's a huge hit!"

At this point, Sister Wang put down the medical supplies in her hand with a little excitement, and suddenly she felt a little emotional:
"It's actually a good idea to leave some of the elderly to do dialysis in the dialysis room, and stop the young people from coming here."

"With the 'Kidney Toxin Clearing Dialysis Needle', those young people don't have to be tied to this machine for the rest of their lives."

Fang Xiaoqin also sighed slightly. How many people working in the dialysis room have not seen human tragedy?

Soon, she adjusted her mood and said:

"By the way, Sister Wang, didn't you say last month that our dialysis center would add more dialysis machines and beds?"

“Can it be increased in this way?”

"Increase your ass!"

Sister Wang once again prepared the medical supplies on the operating table:

"Xiaoqin, you see, the 'Kidney Toxin Clearing Dialysis Needle' has only been on the market for over a month and we have reduced the number of dialysis patients by nearly 20%!"

"If this continues, I estimate that the entire dialysis center will have to reduce its dialysis patients by at least 50%!"

"Let alone adding more dialysis machines, I think Dean Gan should be thankful that we can maintain the current scale of dialysis!"

Nurse Wang is right. As the front-line staff of the dialysis center, they are the ones who can most feel the changes in the flow of people in the dialysis center.

Even the ordinary nurse Sister Wang could see the changes, and Director Gan of West China Hospital also noticed this.

In the Dean's office,

Gan Weiguo stared at the "Dialysis Center Phase II Expansion Procurement Plan" on his desk in a daze.

According to statistics, the number of dialysis patients in China has increased in recent years, and major hospitals across the country have expanded their dialysis rooms.

Two months ago, he also decided to expand the dialysis center again by adding 50 dialysis machines.

But right now...

Qingshan Pharmaceutical's "Kidney Toxin Clearing Dialysis Needle" was launched!
Twenty minutes later, looking at the procurement plan that had been almost finalized, he sighed, picked up the phone on the table and called the procurement department.

"The second phase expansion plan of the dialysis center will be put on hold, the status quo will be maintained, and no additional dialysis machines will be added for the time being."

……

The West China Hospital, one of the top hospitals in the country, has felt the rapid loss of dialysis patients, and the feeling is even more acute in other tertiary hospitals in second- and third-tier cities across the country.

Many hospitals' plans to build new dialysis centers were urgently halted, and those that were planning to expand their dialysis rooms also began to wait and see. With the emergence of "Kidney Toxin Clearing", everyone felt a hint of winter.

Fresenius Medical Care is a German manufacturer specializing in renal dialysis fluid. In 2024, Fresenius Medical Care's hemodialysis business revenue reached US$215.9 billion, making it the world's number one hemodialysis company.

At the same time, Fresenius Medical Care also firmly occupies a core position in China's "hemodialysis market", with a market share of up to 60%.

Previously, the Medical Insurance Bureau had taken the initiative to invite them to negotiate the centralized procurement price many times, but there was no progress and they refused to give in at all.

Shanghai, the China headquarters of Fresenius Medical Care.

Lai Xuefeng, President of the China Region, is a professional manager. Two days ago, he reported the situation of the China market to the German headquarters.

In fact, there was no need for him to give any feedback, as the German headquarters had already felt a considerable impact.

According to news from the US market, sales of major consumables such as dialysis fluid and dialysis filters of Fresenius Medical Care fell by 10% last month.

The reason is simple. As the number of people undergoing dialysis in the hospital's dialysis center decreases, the hospital's purchasing volume naturally declines.

The German headquarters responded quickly. Just two days later, they held an online meeting via video call and quickly decided on the next plan.

Lai Xuefeng looked at the TV screen in front of him and said solemnly:
"Mr. President, you are right, we are about to enter a cold winter!"

"Don't worry, I will immediately start price negotiations with the Huaxia Medical Insurance Bureau. Now we need to stabilize the basic situation."

Fresenius Medical Care responded quickly. They decided to take the simplest and most effective approach to stabilize their market share. That is:

Lower prices and gain support from the Medical Insurance Bureau!
Three days later, in Beijing, at the Gehua International Hotel.

Fresenius Medical Care China sent a middle-aged male negotiation representative, and sitting opposite him was Liu Weiguo, director of the Purchasing Department of the Medical Insurance Bureau.

"Director Liu, let's not beat around the bush. I'll just directly tell you how much sincerity we bring to your bureau this time!"

"At present, the 'hemodialysis consumables package price' we give to your bureau is 765 yuan per person, plus the hospital bed fee, service fee and other drug fees, a total of 900 yuan."

"Now, with the approval of the German headquarters, we are willing to reduce the fee by 765% based on the previous package price of 13 yuan, and give you a package price of 665 yuan per person!"

"This price is 100 yuan lower per person than before. I believe you should be very satisfied."

Liu Weiguo smiled.

The price per person is reduced by 100 yuan. Before, this was the price I could only dream of!

But now!
He glanced at the other party's negotiator, then said slowly:
"I'll tell you a number. Ask your president. The cost of consumables per person has been reduced to 500 yuan!"

"500 yuan?! That's impossible!"

"Impossible? I suggest you think about it carefully."

"Don't even think about it, this price is absolutely impossible!"

In just ten minutes, the negotiations between the two sides ended in a bad mood.

Watching the negotiation team of Fresenius Medical Care walk out of the conference room, Liu Weiguo was not in a hurry, because he knew that soon Qingshan Pharmaceutical's "Kidney Toxin Clearing Dialysis Needle" would use practical actions to shatter the remaining arrogance of Fresenius Medical Care.

"They'll come back for us."

really.

Half a month later, the second month sales of Qingshan Pharmaceutical’s “Kidney Toxin Clearing Dialysis Injection” were released!
Compared with the 5% share of the domestic market and 2% share of the US market in the first month, after becoming famous,
"Kidney Toxin Clearing Dialysis Needle" begins to show its fangs!
In October, the monthly domestic sales of Qingshan Pharmaceutical's "Kidney Toxin Clearing Dialysis" exceeded 30 injections, with sales exceeding 3 million yuan and a market share of 17%!

Monthly sales in the U.S. market exceeded 35 needles, sales exceeded 1.75 million U.S. dollars, and market share climbed to 7%!

The rapid expansion of the domestic market has completely made Fresenius Medical Care unable to sit still. You know!

There are only so many people undergoing dialysis in the country, and Qingshan Pharmaceutical’s “Kidney Toxin Clearing Dialysis Needle” is grabbing all his customers!

A week later, we took the initiative to invite the Medical Insurance Bureau again, hoping to restart price negotiations!

This time, it will be easy to attack and defend the pricing power in the domestic hemodialysis market!
The cold winter is coming, and the "hemodialysis market" has suddenly ushered in a cold winter, and this cold wind has also blown to the headquarters of the German BI company!

Watching the global sales of dialysis consumables such as "dialysis fluid" and "dialysis filters" plummet and prices continue to fall, BI's internal executives fell silent. The silence was terrifying!
The "toxin filtering catalyst" they are developing is also a type of dialysis fluid.
But now, before the drug is even available on the market, the number of people undergoing dialysis worldwide has begun to plummet, and the cost of dialysis consumables has dropped rapidly!
Now a major problem is facing all the senior executives:
What about their catalyst?
Continue research and development?

With such low demand, if we continue to invest manpower and material resources, we may not even be able to recover the costs.

Just give up then?!
　-1 chapter to go, 3 chapters left, time to sleep, bye!
　　
　
(End of this chapter)